c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3793-3800

  Taher, Taher E I ^a   Tjin, Esther P M ^a   Beuling, Esther A ^a   Borst, Jannie ^a   Spaargaren, Marcel ^a   Pals, Steven T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; GENE PRODUCT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE P60; SCATTER FACTOR RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CONTROLLED STUDY; EPITHELIUM; GENE FUNCTION; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036784661     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3793     Document Type: Article

References (66)

1. Bottaro, D. P., J. S. Rubin, D. L. Faletto, A. M. Chan, T. E. Kmiecik, W. G. Vande Woude, and S. A. Aaronson. 1991. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802.
2. Naldini, L., E. Vigna, R. P. Narsimhan, G. Gaudino, R. Zarnegar, G. K. Michalopoulos, and P. M. Comoglio. 1991. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6:501.
3. Van de Voort, R., T. E. Taher, P. W. Derksen, M. Spaargaren, R. van der Neut, and S. T. Pals. 2000. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv. Cancer Res. 79:39.
4. Brinkmann, V., H. Foroutan, M. Sachs, K. M. Weidner, and W. Birchmeier. 1995. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J. Cell Biol. 131:1573.
5. Sachs, M., K. M. Weidner, V. Brinkmann, I. Walther. A. Obermeier, A. Ullrich, and W. Birchmeier. 1996. Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J. Cell Biol. 133:1095.
6. Bladt, F., D. Riethmacher. S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768.
7. Grant, D. S., H. K. Kleinman, I. D. Goldberg, M. M. Bhargava, B. J. Nickoloff, J. L. Kinsella, P. Polverini, and E. M. Rosen. 1993. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90:1937.
8. Bardelli, A., P. Longati, D. Albero, S. Goruppi, C. Schneider, C. Ponzetto, and P. M. Comoglio. 1996. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 15:6205.
9. Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702.
10. Van de Voort, R., T. E. Taher, R. M. Keehnen, L. Smit, M. Groenink, and S. T. Pals. 1997. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J. Exp. Med. 185: 2121.
11. 1 integrins. Blood 89:990.
12. Giordano, S., Z. Zhen, E. Medico, G. Gaudino, F. Galimi, and P. M. Comoglio. 1993. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc. Natl. Acad. Sci. USA 90:649.
13. Rong, S., S. Segal, M. Anver, J. H. Resau, and W. G. Vande Woude. 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91:4731.
14. Weidner, K. M., J. Behrens, J. Vandekerckhove, and W. Birchmeier. 1990. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111:2097.
15. Ponzetto, C., S. Giordano, F. Peverali, V. G. Della, M. L. Abate, G. Vaula, and P. M. Comoglio. 1991. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6:553.
16. Rusciano, D., P. Lorenzoni, and M. M. Burger. 1996. Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity. J. Biol. Chem. 271:20763.
17. Di Renzo, M. F., M. Olivero, A. Giacomini, H. Porte, E. Chastre, L. Mirossay, B. Nordlinger, S. Bretfi, S. Bottardi, and S. Giordano. 1995. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1:147.
18. Jeffers, M., S. Rong, and W. G. Vande Woude. 1996. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16:1115.
19. Cooper, C. S., M. Park, D. G. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and W. G. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29.
20. Jeffers, M., L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, and W. G. Vande Woude. 1997. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA 94:11445.
21. Michieli, P., C. Basilico, S. Pennacchietti, A. Maffe. L. Tamagnone, S. Giordano, A. Bardelli, and P. M. Comoglio. 1999. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene 18:5221.
22. Jeffers, M., M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and W. G. Vande Woude. 1998. The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA 95:14417.
23. Giordano, S., A. Maffe, T. A. Williams, S. Artigiani, P. Gual, A. Bardelli, C. Basilico, P. Michieli, and P. M. Comoglio. 2000. Different point mutations in the met oncogene elicit distinct biological properties. FASEB J. 14:399.
24. Lee, J. H., S. U. Han, H. Cho, B. Jennings, B. Gerrard, M. Dean, L. Schmidt, B. Zbar, and W. G. Vande Woude. 2000. A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene 19:4947.
25. Derksen, P. W. B., R. M. J. Keehnen, L. M. Evers, M. H. J. van Oers, M. Spaargaren, and S. T. Pals. 2002. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99:1405.
26. Borset, M., E. Lien, T. Espevik. E. Helseth, A. Waage, and A. Sundan. 1996. Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. J. Biol. Chem. 271:24655.
27. Takai, K. J. Hara, K. Matsumoto, G. Hosoi, Y. Osugi, A. Tawa, S. Okada, and T. Nakamura. 1997. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood 89:1560.
28. Seidel, C., M. Borset, I. Turesson, N. Abildgaard, A. Sundan, and A. Waage. 1998. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma: The Nordic Myeloma Study Group. Blood 91:806.
29. Ponzetto, C., A. Bardelli, Z. Zhen, F. Maina, Z. P. dalla Zonca, S. Giordano, A. Graziani, G. Panayotou, and P. M. Comoglio. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77:261.
30. Weidner, K. M., S. Di Cesare, M. Sachs, V. Brinkmann, J. Behrens, and W. Birchmeier. 1996. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384:173.
31. Schaeper, U., N. H. Gehring, K. P. Fuchs, M. Sachs, B. Kempkes, and W. Birchmeier. 2000. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149:1419.
32. Sakkab, D., M. Lewitzky, G. Posern, U. Schaeper, M. Sachs, W. Birchmeier, and S. M. Feller. 2000. Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL. J. Biol. Chem. 275:10772.
33. Van de Voort, R., T. E. Taher, V. J. Wielenga, M. Spaargaren, R. Prevo, L. Smit, G. David, G. Hartmann, E. Gherardi, and S. T. Pals. 1999. Heparan sulfatemodified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 274:6499.
34. Van de Voort, R., R. M. Keehnen, E. A. Beuling, M. Spaargaren, and S. T. Pals. 2000. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans. J. Exp. Med. 192:1115.
35. Kim, T. J., Y. T. Kim, and S. Pillai. 1995. Association of activated phosphatidylinositol 3-kinase with p120cbl in antigen receptor-ligated B cells. J. Biol. Chem. 270:27504.
36. Cory, G. O., R. C. Lovering, S. Hinshelwood, L. MacCarthy-Morrogh, R. J. Levinsky, and C. Kinnon. 1995. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 182:611.
37. lyn, in the B cell antigen receptor-mediated signaling. J. Exp. Med. 183:675.
38. Panchamoorthy, G., T. Fukazawa, S. Miyake, S. Soltoff, K. Reedquist, B. Druker, S. Shoelson, L. Cantley, and H. Band. 1996. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 271:3187.
39. Weidner, K. M., M. Sachs, D. Riethmacher, and W. Birchmeier. 1995. Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc. Natl. Acad. Sci. USA 92:2597.
40. Smit, L., and J. Borst. 1997. The Cbl family of signal transduction molecules. Crit. Rev. Oncog. 8:359.
41. Levkowitz, G., H. Waterman, E. Zamir, Z. Kam, S. Oved, W. Y. Langdon, L. Beguinot, B. Geiger, and Y. Yarden. 1998. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:3663.
42. Miyake, S., K. P. Mullane-Robinson, N. L. Lill, P. Douillard, and H. Band. 1999. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation: a critical role for Cbl tyrosine kinase-binding domain. J. Biol. Chem. 274:16619.
43. Fixman, E. D., M. A. Naujokas, G. A. Rodrigues, M. F. Moran, and M. Park. 1995. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Oncogene 10:237.
44. Nguyen, L., M. Holgado-Madruga, C. Maroun, E. D. Fixman, D. Kamikura, T. Fournier, A. Charest, M. L. Tremblay, A. J. Wong, and M. Park. 1997. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J. Biol. Chem. 272:20811.
45. Pelicci, G., S. Giordano, Z. Zhen, A. E. Salcini, L. Lanfrancone, A. Bardelli, G. Panayotou, M. D. Waterfield, C. Ponzetto, and P. G. Pelicci. 1995. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene 10:1631.
46. Ponzetto, C., Z. Zhen, E. Audero, F. Maina, A. Bardelli, M. L. Basile, S. Giordano, R. Narsimhan, and P. Comoglio. 1996. Specific uncoupling of GRB2 from the Met receptor: differential effects on transformation and motility. J. Biol. Chem. 271:14119.
47. Zhu, H., M. A. Naujokas, E. D. Fixman, K. Torossian, and M. Park. 1994. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J. Biol. Chem. 269:29943.
48. Garcia-Guzman, M., E. Larsen, and K. Vuori. 2000. The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: a role for the adaptor protein Crk. Oncogene 19:4058.
49. Fournier, T. M., L. Lamorte, C. R. Maroun, M. Lupher, H. Band, W. Langdon, and M. Park. 2000. Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion. Mol. Biol. Cell 11: 3397.
50. Fixman, E. D., M. Holgado-Madruga, L. Nguyen, D. M. Kamikura, T. M. Fournier, A. J. Wong, and M. Park. 1997. Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1. J. Biol. Chem. 272:20167.
51. Langdon, W. Y., J. W. Hartley, S. P. Klinken, S. K. Ruscetti, and H. C. Morse. 1989. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl. Acad. Sci. USA 86:1168.
52. Feshchenko, E. A., W. Y. Langdon, and A. Y. Tsygankov. 1998. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 273:8323.
53. Hunter, S., E. A. Burton, S. C. Wu, and S. M. Anderson. 1999. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J. Biol. Chem. 274:2097.
54. Miyake, S., M. L. J. Lupher, C. E. Andoniou, N. L. Lill, S. Ota, P. Douillard, N. Rao, and H. Band. 1997. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction. Crit. Rev. Oncog. 8:189.
55. Reedquist, K. A., E. Ross, E. A. Koop, R. M. Wolthuis, F. J. Zwartkruis, Y. van Kooyk, M. Salmon, C. D. Buckley, and J. L. Bos. 2000. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148:1151.
56. 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO J. 17:4391.
57. 1-integrin-mediated cell adhesion by the Cbl adaptor protein. Curr. Biol. 8:814.
58. Miyake, S., M. L. J. Lupher, B. Druker, and H. Band. 1998. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor α. Proc. Natl. Acad. Sci. USA 95:7927.
59. Lee, P. S., Y. Wang, M. G. Dominguez, Y. G. Yeung, M. A. Murphy, D. D. Bowtell, and E. R. Stanley. 1999. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 18:3616.
60. Joazeiro, C. A., S. S. Wing, H. Huang, J. D. Leverson, T. Hunter, and Y. C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309.
61. Jeffers, M., G. A. Taylor, K. M. Weidner, S. Omura, and W. G. Vande Woude. 1997. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 17:799.
62. Yoon, C. H., J. Lee, G. D. Jongeward, and P. W. Sternberg. 1995. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian protooncogene c-cbl. Science 269:1102.
63. Ueno, H., K. Sasaki, K. Miyagawa, H. Honda, K. Mitani, Y. Yazaki, and H. Hirai. 1997. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem. 272:8739.
64. Thien, C. B., and W. Y. Langdon. 1997. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene 15: 2909.
65. Bonita, D. P., S. Miyake, M. L. J. Lupher, W. Y. Langdon, and H. Band. 1997. Phosphotyrosine binding domain-dependent up-regulation of the platelet-derived growth factor receptor α signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol. Cell. Biol. 17:4597.
66. Peschard, P., T. M. Fournier, L., Lamorte, M. A., Naujokas, H. Band, W.Y., Langdon, M. Park. 2001. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine knase converts it into a transforming protein. Mol. Cell 8:995.